Corporate
|
1 min read
Corporate
|
2 min read
A.forall is taking important steps towards the future
Business
US
|
2 min read
Direct Commercialization of Sodium Acetate Injection 2mEq/mL in the U.S.
Business
US
|
2 min read
Launch of Tromethamine Injection in the U.S. Market
Business
US
|
2 min read
Launch of Dexmedetomidine Hydrochloride Injection in the U.S. Market
Corporate
US
|
2 min read
A.forall welcomes Libor Matyasek as new CFO
Business
US
|
2 min read
Launch of Magnesium Sulfate in Water for Injection in the U.S. Market
Business
US
|
1 min read
New Sodium Acetate Injection Concentration
Business
US
|
1 min read
Launch of a Generic Version of Pyridostigmine Bromide Syrup
Business
US
|
2 min read
Milla Pharmaceuticals Receives FDA Approval for Dexmedetomidine Hydrochloride Injection
Business
US
|
2 min read
Company milestone : Magnesium Sulfate in Water for Injection approval for commercialization !
Business
US
|
1 min read
Second Paragraph IV Filing for an Alter Pharma Product in US
Business
US
|
3 min read
Fourth Alter Pharma product for US market receives ANDA approval from FDA
Business
US
|
5 min read
Third Alter Pharma product for US market receives ANDA approval from FDA
Business
US
|
5 min read
Alter Pharma subsidiary, Milla Pharmaceuticals, gets FDA approval for a generic version of Sodium Acetate Injection 2MEQ/mL
Business
US
|
3 min read
First Alter Pharma product hits the US market: Sandoz launches generic injectable acetaminophen developed by Milla Pharmaceuticals
Follow us on LinkedIn
We regularly post about the newest updates, product launches, partnerships and employee stories.